Efficacy and Safety of Micropulse Transscleral Cyclophotocoagulation.

ABSTRACT:

Background

Early studies have shown that micropulse transscleral cyclophotocoagulation (MP-TSCPC) might be an effective and safe treatment option for lowering intraocular pressure (IOP). These studies were, however, somewhat limited, in particular by their retrospective nature and the length of follow-up. Therefore, we assessed the efficacy and safety of this novel treatment in a large cohort for up to 4 years.

Methods

We performed a prospective cohort study, including all patients who were treated with MP-TSCPC since November 2017. The primary outcome was a reduction of IOP and the number of IOP-lowering medications.

Results

The mean ± standard deviation baseline IOP and number of IOP-lowering medications were 26.6 ± 10.8 mmHg and 3.3 ± 1.3. IOP was reduced by 8.2 ±

SUBMITTER: de Vries VA 

PROVIDER: S-EPMC9224545 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature